Record #25423

Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4

Notes from Retraction Watch

see also: https://blogs.rsc.org/ra/2021/01/21/rsc-paper-mill-retractions/?doing_wp_cron=1611230128.9542400836944580078125

Citation lifecycle

How this paper is being cited

Pre-retraction
2
Same day
0
Post-retraction
3
% post-retraction
60.0%
~0.7 citations/yr before retraction · ~0.5 citations/yr after
citing papers

Who is still citing this work

Loading…